If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?When I last covered Intellia Therapeutics, Inc. (NASDAQ: NTLA ) for Seeking Alpha at the end of May, the share price of the Cambridge, Massachusetts-based pharma company, developing gene therapies using CRISPR tech ...